Caitlin Nass, NP
Adult Health · Baltimore, MDNPI 1437273067
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Sanofi-aventis U.S. LLC accounts for 61.0% of it on its own, with 17 other manufacturers making up the rest. Among adult health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $272.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$28K
- Dexcom, Inc.$10K
- Corcept Therapeutics$6K
- Abbott$519
- Novo Nordisk$491
- Lilly USA, LLC$362
- plus $837 from 12 others
What the payments were for
- Consulting fees$3,8368%
- Speaking & faculty fees$23,40451%
- Travel & lodging$11,86826%
- Food & beverage$6,85415%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 51 | $28,054 |
| Dexcom, Inc. | 31 | $10,138 |
| Corcept Therapeutics | 23 | $5,594 |
| Abbott | 14 | $519 |
| Novo Nordisk | 18 | $491 |
| Lilly USA, LLC | 11 | $362 |
| Insulet Corporation | 1 | $175 |
| Medtronic | 4 | $163 |
| Exact Sciences | 5 | $122 |
| BETA Bionics, Inc. | 1 | $114 |
| Tandem Diabetes Care, Inc. | 1 | $70 |
| Lundbeck LLC | 2 | $44 |
| Amgen | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $24 |
| Bayer | 1 | $23 |
| Pfizer | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$9,124
- DEXCOM STELO GLUCOSE BIOSENSOR$8,983
- TZIELD$6,578
- Korlym$5,132
- iLet Bionic Pancreas$341
- Omnipod$175
- DEXCOM G6 TRANSMITTER$116
- iLet Insulin Infusion Kit Inset$114
- iLet Insulin Infusion Kit Contact Detach$114
- ZEPBOUND$108
How this compares
$45,994 in reported general payments places this provider in the 95th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 24 | $34,661 |
| OzempicSemaglutide | 21 | $25,360 |
| MounjaroTirzepatide | 17 | $14,012 |
| JardianceEmpagliflozin | 14 | $10,174 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $5,535 |
| Novolog FlexpenInsulin Aspart | 15 | $2,587 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 12 | $932 |
| Metformin Hcl ErMetformin Hcl | 24 | $194 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $362 | $48,67341 claims |
| Novo NordiskOzempic | $491 | $25,36021 claims |
| Boehringer IngelheimJardiance | $19 | $10,17414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 542 adult health providers in Maryland.
Other adult health in Baltimore
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Brendon BowerBaltimore$64K
- Sarah RileyBaltimore$24K
- Monica LovinsBaltimore$18K
- Elizabeth ChandlerBaltimore$17K
- Clifton DawsonBaltimore$14K
- Selina YeasminBaltimore$8K
- Andrea ArroyoBaltimore$8K
- Kathleen CostelloBaltimore$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.